Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update on Ovarian Suppression Summary-Reference-Cited by-同舟云学术

Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update on Ovarian Suppression Summary

Published:2016-04 Issue:4 Volume:12 Page:390-393
ISSN:1554-7477
Container-title:Journal of Oncology Practice
language:en
Short-container-title:JOP

Author:

Burstein Harold J.¹,Lacchetti Christina¹,Griggs Jennifer J.¹

Affiliation:

1. Dana-Farber Cancer Institute, Boston, MA; ASCO, Alexandria, VA; University of Michigan, Ann Arbor, MI

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Health Policy,Oncology(nursing),Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JOP.2016.011239

Reference8 articles.

1. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

2. Ovarian Ablation or Suppression in Premenopausal Early Breast Cancer: Results From the International Adjuvant Breast Cancer Ovarian Ablation or Suppression Randomized Trial

3. Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials

4. Longer Therapy, Iatrogenic Amenorrhea, and Survival in Early Breast Cancer

5. Tamoxifen After Adjuvant Chemotherapy for Premenopausal Women With Lymph Node-Positive Breast Cancer: International Breast Cancer Study Group Trial 13-93

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of aerobic exercise on neurocognitive function in postmenopausal women receiving endocrine therapy for breast cancer: The Exercise Program in Cancer and Cognition randomized controlled trial;Psycho-Oncology;2024-01-29

2. The roles of anti-Müllerian hormone in breast cancer;Endocrine-Related Cancer;2023-07-06

3. Tryptophan and Kynurenine Pathway Metabolites and Psychoneurological Symptoms Among Breast Cancer Survivors;Pain Management Nursing;2023-02

4. Adapting an Evidence-Based Exercise and Education Program for Older Breast Cancer Survivors for the REJOIN Trial;Journal of Aging and Physical Activity;2023-02-01

5. PATTERNS OF FAILURE AND SURVIVAL IN ER/PR POSITIVE CARCINOMA BREAST WITH CONVENTIONAL VERSUS EXTENDED HORMONAL THERAPY.;INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH;2022-12-01